OraSure Technologies | OSUR - Selling And Administration Expenses

Stock Price
2.94
Daily Change
-0.07 -2.33%
Monthly
8.49%
Yearly
-11.18%
Q1 Forecast
3.05

OraSure Technologies reported $-0.06 in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
AngioDynamics USD 35.99M 14K Feb/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bio Techne USD 113.69M 2.52M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
Bruker USD 247.2M 4.7M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 383M 28M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Illumina USD 283M 27M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
Mesa Laboratories USD 27.31M 380K Sep/2024
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Myriad Genetics USD 129M 1.3M Sep/2025
OraSure Technologies USD -0.06 0.05 Sep/2024
Quidel USD 194.4M 7.5M Dec/2025
Repligen USD 74.36M 703K Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
STAAR Surgical USD 38.94M 20.44M Dec/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Trinity Biotech USD 6.19M 2.18M Sep/2025
Waters USD 240.01M 25.78M Dec/2025